Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TSHA

Taysha Gene Therapies (TSHA)

Taysha Gene Therapies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TSHA
DateTimeSourceHeadlineSymbolCompany
15/05/202406:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
15/05/202406:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSHATaysha Gene Therapies Inc
15/05/202406:01GlobeNewswire Inc.Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TSHATaysha Gene Therapies Inc
08/05/202406:05GlobeNewswire Inc.Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14NASDAQ:TSHATaysha Gene Therapies Inc
04/05/202406:05GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
02/05/202422:00GlobeNewswire Inc.Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett SyndromeNASDAQ:TSHATaysha Gene Therapies Inc
05/04/202423:00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
21/03/202404:30AllPennyStocks.comAnother Biotech Steals The Show Following Major Clinical Data ReleaseNASDAQ:TSHATaysha Gene Therapies Inc
20/03/202407:01GlobeNewswire Inc.Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical UpdatesNASDAQ:TSHATaysha Gene Therapies Inc
19/03/202422:27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:TSHATaysha Gene Therapies Inc
15/03/202407:26GlobeNewswire Inc.Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19NASDAQ:TSHATaysha Gene Therapies Inc
02/03/202409:08GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
01/03/202400:00GlobeNewswire Inc.Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett SyndromeNASDAQ:TSHATaysha Gene Therapies Inc
16/02/202408:01GlobeNewswire Inc.Taysha Gene Therapies Provides Update on Deprioritized Pipeline ProgramsNASDAQ:TSHATaysha Gene Therapies Inc
10/02/202408:24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TSHATaysha Gene Therapies Inc
03/02/202400:00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
23/01/202400:00GlobeNewswire Inc.Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual ConferenceNASDAQ:TSHATaysha Gene Therapies Inc
11/01/202400:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
11/01/202400:00GlobeNewswire Inc.Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett SyndromeNASDAQ:TSHATaysha Gene Therapies Inc
06/01/202400:00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
21/12/202308:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
21/12/202308:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TSHATaysha Gene Therapies Inc
19/12/202323:30PR Newswire (US)Trinity Capital Inc. Provides $40 Million Term Loan to Taysha Gene TherapiesNASDAQ:TSHATaysha Gene Therapies Inc
30/11/202300:00GlobeNewswire Inc.Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome PatientsNASDAQ:TSHATaysha Gene Therapies Inc
16/11/202308:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
15/11/202308:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
15/11/202308:08GlobeNewswire Inc.Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical UpdatesNASDAQ:TSHATaysha Gene Therapies Inc
08/11/202300:00GlobeNewswire Inc.Taysha Gene Therapies to Release Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 14NASDAQ:TSHATaysha Gene Therapies Inc
04/11/202307:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
04/11/202307:40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:TSHA

Your Recent History

Delayed Upgrade Clock